KF

Kamila Filipiak

Head Of Pharmacovigilance And Clinical Safety Department at PVpharm

Kamila Filipiak, PhD, is currently serving as the Head of Pharmacovigilance and Clinical Safety department at PVpharm. Previous experiences include roles such as a PV Project Lead at IQVIA and a Researcher at Universidad CEU San Pablo. Kamila has a background in molecular biology and medicinal chemistry, holding a Doctor of Philosophy (PhD) in Medicinal Chemistry.

Location

Madrid, Spain

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


PVpharm

www.pvpharm.com https://www.pvpharm.com/careers -PVpharm provides consultancy services in Pharmacovigilance for the Pharmaceutical Industry -We work independently or in collaboration with other PV service providers / CRO's -EU QPPV service -Local QPPV services for Spain -Training pharmacovigilance and GVP -Pharmacovigilance GVP Audits -EudraVigilance EVWeb and the XEVMPD (eXtended EudraVigilance Medicinal Product Dictionary). Possibility internal certified on-site training for pharmaceutical companies. -Registration with Eudravigilance for Pharmaceutical companies. -Introduction of information of medicinal products in the XEVMPD. -Development of IDMP implementation consultancy services. -Case management of suspected adverse reactions, including contact with reporters, MedDRA coding, Data Entry and Electronic reporting to health authorities. -Literature searches for Pharmacovigilance. -Implementation of the company's Pharmacovigilance system, including Standard Operating Procedures for Pharmacovigilance (SOPs / PNTs). -Development and revision of Pharmacovigilance documents, including Periodic Safety Update Reports (PSURs), Risk management plans (RMPs) and Elaboration of the Pharmacovigilance System Master File. JOBS: please visit our website at www.pvpharm.com


Headquarters

Almería, Spain

Employees

11-50

Links